New multiple sclerosis treatment trial compares stem cell transplantation to best available drugs
NIH-funded study focuses on severe forms of relapsing MS. Source NIH A clinical has begun trial testing an experimental stem cell treatment against the best available biologic therapies for severe forms of relapsing multiple sclerosis (MS). The trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of